Global Biologics Monoclonal Antibodies Drug Market 2023 by Company, Regions, Type and Application, Forecast to 2029
![](/report_cover/9988/global-biologics-monoclonal-antibodies-drug-market-2023-by-company-regions-type-n-application-forecast-to-2029_en.gif)
According to our (Global Info Research) latest study, the global Biologics Monoclonal Antibodies Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
This report is a detailed and comprehensive analysis for global Biologics Monoclonal Antibodies Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biologics Monoclonal Antibodies Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biologics Monoclonal Antibodies Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biologics Monoclonal Antibodies Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biologics Monoclonal Antibodies Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biologics Monoclonal Antibodies Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biologics Monoclonal Antibodies Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biologics Monoclonal Antibodies Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Biologics Monoclonal Antibodies Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biologics Monoclonal Antibodies Drug, with revenue, gross margin and global market share of Biologics Monoclonal Antibodies Drug from 2018 to 2023.
Chapter 3, the Biologics Monoclonal Antibodies Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biologics Monoclonal Antibodies Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologics Monoclonal Antibodies Drug.
Chapter 13, to describe Biologics Monoclonal Antibodies Drug research findings and conclusion.
Monoclonal antibodies are immune system proteins that are created in the lab. Antibodies are produced naturally by your body and help the immune system recognize germs that cause disease, such as bacteria and viruses, and mark them for destruction. Like your body’s own antibodies, monoclonal antibodies recognize specific targets.
This report is a detailed and comprehensive analysis for global Biologics Monoclonal Antibodies Drug market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Biologics Monoclonal Antibodies Drug market size and forecasts, in consumption value ($ Million), 2018-2029
Global Biologics Monoclonal Antibodies Drug market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Biologics Monoclonal Antibodies Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Biologics Monoclonal Antibodies Drug market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Biologics Monoclonal Antibodies Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Biologics Monoclonal Antibodies Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Amgen, AbbVie, Sanofi and Johnson & Johnson, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Biologics Monoclonal Antibodies Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Infliximab
- Rituximab
- Trastuzumab
- Adalimumab
- Other
- Cancer
- Autoimmune Disease
- Other
- Roche
- Amgen
- AbbVie
- Sanofi
- Johnson & Johnson
- Pfizer
- Eli Lilly
- Novartis
- Merck
- Biogen
- Sobi
- Innovent Biologics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Biologics Monoclonal Antibodies Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Biologics Monoclonal Antibodies Drug, with revenue, gross margin and global market share of Biologics Monoclonal Antibodies Drug from 2018 to 2023.
Chapter 3, the Biologics Monoclonal Antibodies Drug competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biologics Monoclonal Antibodies Drug market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Biologics Monoclonal Antibodies Drug.
Chapter 13, to describe Biologics Monoclonal Antibodies Drug research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Biologics Monoclonal Antibodies Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biologics Monoclonal Antibodies Drug by Type
1.3.1 Overview: Global Biologics Monoclonal Antibodies Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type in 2022
1.3.3 Infliximab
1.3.4 Rituximab
1.3.5 Trastuzumab
1.3.6 Adalimumab
1.3.7 Other
1.4 Global Biologics Monoclonal Antibodies Drug Market by Application
1.4.1 Overview: Global Biologics Monoclonal Antibodies Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cancer
1.4.3 Autoimmune Disease
1.4.4 Other
1.5 Global Biologics Monoclonal Antibodies Drug Market Size & Forecast
1.6 Global Biologics Monoclonal Antibodies Drug Market Size and Forecast by Region
1.6.1 Global Biologics Monoclonal Antibodies Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Biologics Monoclonal Antibodies Drug Market Size by Region, (2018-2029)
1.6.3 North America Biologics Monoclonal Antibodies Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Biologics Monoclonal Antibodies Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size and Prospect (2018-2029)
1.6.6 South America Biologics Monoclonal Antibodies Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Biologics Monoclonal Antibodies Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Biologics Monoclonal Antibodies Drug Product and Solutions
2.1.4 Roche Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Biologics Monoclonal Antibodies Drug Product and Solutions
2.2.4 Amgen Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Amgen Recent Developments and Future Plans
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Biologics Monoclonal Antibodies Drug Product and Solutions
2.3.4 AbbVie Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AbbVie Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Biologics Monoclonal Antibodies Drug Product and Solutions
2.4.4 Sanofi Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Biologics Monoclonal Antibodies Drug Product and Solutions
2.5.4 Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Biologics Monoclonal Antibodies Drug Product and Solutions
2.6.4 Pfizer Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Biologics Monoclonal Antibodies Drug Product and Solutions
2.7.4 Eli Lilly Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Eli Lilly Recent Developments and Future Plans
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Biologics Monoclonal Antibodies Drug Product and Solutions
2.8.4 Novartis Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Novartis Recent Developments and Future Plans
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Biologics Monoclonal Antibodies Drug Product and Solutions
2.9.4 Merck Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck Recent Developments and Future Plans
2.10 Biogen
2.10.1 Biogen Details
2.10.2 Biogen Major Business
2.10.3 Biogen Biologics Monoclonal Antibodies Drug Product and Solutions
2.10.4 Biogen Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Biogen Recent Developments and Future Plans
2.11 Sobi
2.11.1 Sobi Details
2.11.2 Sobi Major Business
2.11.3 Sobi Biologics Monoclonal Antibodies Drug Product and Solutions
2.11.4 Sobi Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sobi Recent Developments and Future Plans
2.12 Innovent Biologics
2.12.1 Innovent Biologics Details
2.12.2 Innovent Biologics Major Business
2.12.3 Innovent Biologics Biologics Monoclonal Antibodies Drug Product and Solutions
2.12.4 Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Innovent Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biologics Monoclonal Antibodies Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Biologics Monoclonal Antibodies Drug by Company Revenue
3.2.2 Top 3 Biologics Monoclonal Antibodies Drug Players Market Share in 2022
3.2.3 Top 6 Biologics Monoclonal Antibodies Drug Players Market Share in 2022
3.3 Biologics Monoclonal Antibodies Drug Market: Overall Company Footprint Analysis
3.3.1 Biologics Monoclonal Antibodies Drug Market: Region Footprint
3.3.2 Biologics Monoclonal Antibodies Drug Market: Company Product Type Footprint
3.3.3 Biologics Monoclonal Antibodies Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biologics Monoclonal Antibodies Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biologics Monoclonal Antibodies Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Biologics Monoclonal Antibodies Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2029)
6.2 North America Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2029)
6.3 North America Biologics Monoclonal Antibodies Drug Market Size by Country
6.3.1 North America Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2029)
6.3.2 United States Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2029)
7.2 Europe Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2029)
7.3 Europe Biologics Monoclonal Antibodies Drug Market Size by Country
7.3.1 Europe Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
7.3.3 France Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size by Region
8.3.1 Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Region (2018-2029)
8.3.2 China Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
8.3.5 India Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2029)
9.2 South America Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2029)
9.3 South America Biologics Monoclonal Antibodies Drug Market Size by Country
9.3.1 South America Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country
10.3.1 Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Biologics Monoclonal Antibodies Drug Market Drivers
11.2 Biologics Monoclonal Antibodies Drug Market Restraints
11.3 Biologics Monoclonal Antibodies Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Biologics Monoclonal Antibodies Drug Industry Chain
12.2 Biologics Monoclonal Antibodies Drug Upstream Analysis
12.3 Biologics Monoclonal Antibodies Drug Midstream Analysis
12.4 Biologics Monoclonal Antibodies Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Biologics Monoclonal Antibodies Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biologics Monoclonal Antibodies Drug by Type
1.3.1 Overview: Global Biologics Monoclonal Antibodies Drug Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type in 2022
1.3.3 Infliximab
1.3.4 Rituximab
1.3.5 Trastuzumab
1.3.6 Adalimumab
1.3.7 Other
1.4 Global Biologics Monoclonal Antibodies Drug Market by Application
1.4.1 Overview: Global Biologics Monoclonal Antibodies Drug Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cancer
1.4.3 Autoimmune Disease
1.4.4 Other
1.5 Global Biologics Monoclonal Antibodies Drug Market Size & Forecast
1.6 Global Biologics Monoclonal Antibodies Drug Market Size and Forecast by Region
1.6.1 Global Biologics Monoclonal Antibodies Drug Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Biologics Monoclonal Antibodies Drug Market Size by Region, (2018-2029)
1.6.3 North America Biologics Monoclonal Antibodies Drug Market Size and Prospect (2018-2029)
1.6.4 Europe Biologics Monoclonal Antibodies Drug Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size and Prospect (2018-2029)
1.6.6 South America Biologics Monoclonal Antibodies Drug Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Biologics Monoclonal Antibodies Drug Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Biologics Monoclonal Antibodies Drug Product and Solutions
2.1.4 Roche Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Biologics Monoclonal Antibodies Drug Product and Solutions
2.2.4 Amgen Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Amgen Recent Developments and Future Plans
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Biologics Monoclonal Antibodies Drug Product and Solutions
2.3.4 AbbVie Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AbbVie Recent Developments and Future Plans
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Biologics Monoclonal Antibodies Drug Product and Solutions
2.4.4 Sanofi Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Sanofi Recent Developments and Future Plans
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business
2.5.3 Johnson & Johnson Biologics Monoclonal Antibodies Drug Product and Solutions
2.5.4 Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Johnson & Johnson Recent Developments and Future Plans
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer Biologics Monoclonal Antibodies Drug Product and Solutions
2.6.4 Pfizer Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Pfizer Recent Developments and Future Plans
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business
2.7.3 Eli Lilly Biologics Monoclonal Antibodies Drug Product and Solutions
2.7.4 Eli Lilly Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Eli Lilly Recent Developments and Future Plans
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Biologics Monoclonal Antibodies Drug Product and Solutions
2.8.4 Novartis Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Novartis Recent Developments and Future Plans
2.9 Merck
2.9.1 Merck Details
2.9.2 Merck Major Business
2.9.3 Merck Biologics Monoclonal Antibodies Drug Product and Solutions
2.9.4 Merck Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck Recent Developments and Future Plans
2.10 Biogen
2.10.1 Biogen Details
2.10.2 Biogen Major Business
2.10.3 Biogen Biologics Monoclonal Antibodies Drug Product and Solutions
2.10.4 Biogen Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Biogen Recent Developments and Future Plans
2.11 Sobi
2.11.1 Sobi Details
2.11.2 Sobi Major Business
2.11.3 Sobi Biologics Monoclonal Antibodies Drug Product and Solutions
2.11.4 Sobi Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Sobi Recent Developments and Future Plans
2.12 Innovent Biologics
2.12.1 Innovent Biologics Details
2.12.2 Innovent Biologics Major Business
2.12.3 Innovent Biologics Biologics Monoclonal Antibodies Drug Product and Solutions
2.12.4 Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Innovent Biologics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Biologics Monoclonal Antibodies Drug Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Biologics Monoclonal Antibodies Drug by Company Revenue
3.2.2 Top 3 Biologics Monoclonal Antibodies Drug Players Market Share in 2022
3.2.3 Top 6 Biologics Monoclonal Antibodies Drug Players Market Share in 2022
3.3 Biologics Monoclonal Antibodies Drug Market: Overall Company Footprint Analysis
3.3.1 Biologics Monoclonal Antibodies Drug Market: Region Footprint
3.3.2 Biologics Monoclonal Antibodies Drug Market: Company Product Type Footprint
3.3.3 Biologics Monoclonal Antibodies Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Biologics Monoclonal Antibodies Drug Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biologics Monoclonal Antibodies Drug Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application (2018-2023)
5.2 Global Biologics Monoclonal Antibodies Drug Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2029)
6.2 North America Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2029)
6.3 North America Biologics Monoclonal Antibodies Drug Market Size by Country
6.3.1 North America Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2029)
6.3.2 United States Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
6.3.3 Canada Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
6.3.4 Mexico Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2029)
7.2 Europe Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2029)
7.3 Europe Biologics Monoclonal Antibodies Drug Market Size by Country
7.3.1 Europe Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2029)
7.3.2 Germany Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
7.3.3 France Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
7.3.5 Russia Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
7.3.6 Italy Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biologics Monoclonal Antibodies Drug Market Size by Region
8.3.1 Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Region (2018-2029)
8.3.2 China Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
8.3.3 Japan Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
8.3.4 South Korea Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
8.3.5 India Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
8.3.7 Australia Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2029)
9.2 South America Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2029)
9.3 South America Biologics Monoclonal Antibodies Drug Market Size by Country
9.3.1 South America Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2029)
9.3.2 Brazil Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
9.3.3 Argentina Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biologics Monoclonal Antibodies Drug Market Size by Country
10.3.1 Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2029)
10.3.2 Turkey Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
10.3.4 UAE Biologics Monoclonal Antibodies Drug Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Biologics Monoclonal Antibodies Drug Market Drivers
11.2 Biologics Monoclonal Antibodies Drug Market Restraints
11.3 Biologics Monoclonal Antibodies Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Biologics Monoclonal Antibodies Drug Industry Chain
12.2 Biologics Monoclonal Antibodies Drug Upstream Analysis
12.3 Biologics Monoclonal Antibodies Drug Midstream Analysis
12.4 Biologics Monoclonal Antibodies Drug Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Biologics Monoclonal Antibodies Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biologics Monoclonal Antibodies Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biologics Monoclonal Antibodies Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biologics Monoclonal Antibodies Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Biologics Monoclonal Antibodies Drug Product and Solutions
Table 8. Roche Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Amgen Company Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Biologics Monoclonal Antibodies Drug Product and Solutions
Table 13. Amgen Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Amgen Recent Developments and Future Plans
Table 15. AbbVie Company Information, Head Office, and Major Competitors
Table 16. AbbVie Major Business
Table 17. AbbVie Biologics Monoclonal Antibodies Drug Product and Solutions
Table 18. AbbVie Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. AbbVie Recent Developments and Future Plans
Table 20. Sanofi Company Information, Head Office, and Major Competitors
Table 21. Sanofi Major Business
Table 22. Sanofi Biologics Monoclonal Antibodies Drug Product and Solutions
Table 23. Sanofi Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Sanofi Recent Developments and Future Plans
Table 25. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 26. Johnson & Johnson Major Business
Table 27. Johnson & Johnson Biologics Monoclonal Antibodies Drug Product and Solutions
Table 28. Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Johnson & Johnson Recent Developments and Future Plans
Table 30. Pfizer Company Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Biologics Monoclonal Antibodies Drug Product and Solutions
Table 33. Pfizer Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Pfizer Recent Developments and Future Plans
Table 35. Eli Lilly Company Information, Head Office, and Major Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Biologics Monoclonal Antibodies Drug Product and Solutions
Table 38. Eli Lilly Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Eli Lilly Recent Developments and Future Plans
Table 40. Novartis Company Information, Head Office, and Major Competitors
Table 41. Novartis Major Business
Table 42. Novartis Biologics Monoclonal Antibodies Drug Product and Solutions
Table 43. Novartis Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Novartis Recent Developments and Future Plans
Table 45. Merck Company Information, Head Office, and Major Competitors
Table 46. Merck Major Business
Table 47. Merck Biologics Monoclonal Antibodies Drug Product and Solutions
Table 48. Merck Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Merck Recent Developments and Future Plans
Table 50. Biogen Company Information, Head Office, and Major Competitors
Table 51. Biogen Major Business
Table 52. Biogen Biologics Monoclonal Antibodies Drug Product and Solutions
Table 53. Biogen Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Recent Developments and Future Plans
Table 55. Sobi Company Information, Head Office, and Major Competitors
Table 56. Sobi Major Business
Table 57. Sobi Biologics Monoclonal Antibodies Drug Product and Solutions
Table 58. Sobi Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Sobi Recent Developments and Future Plans
Table 60. Innovent Biologics Company Information, Head Office, and Major Competitors
Table 61. Innovent Biologics Major Business
Table 62. Innovent Biologics Biologics Monoclonal Antibodies Drug Product and Solutions
Table 63. Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Innovent Biologics Recent Developments and Future Plans
Table 65. Global Biologics Monoclonal Antibodies Drug Revenue (USD Million) by Players (2018-2023)
Table 66. Global Biologics Monoclonal Antibodies Drug Revenue Share by Players (2018-2023)
Table 67. Breakdown of Biologics Monoclonal Antibodies Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Biologics Monoclonal Antibodies Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Biologics Monoclonal Antibodies Drug Players
Table 70. Biologics Monoclonal Antibodies Drug Market: Company Product Type Footprint
Table 71. Biologics Monoclonal Antibodies Drug Market: Company Product Application Footprint
Table 72. Biologics Monoclonal Antibodies Drug New Market Entrants and Barriers to Market Entry
Table 73. Biologics Monoclonal Antibodies Drug Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Biologics Monoclonal Antibodies Drug Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Biologics Monoclonal Antibodies Drug Consumption Value Share by Type (2018-2023)
Table 76. Global Biologics Monoclonal Antibodies Drug Consumption Value Forecast by Type (2024-2029)
Table 77. Global Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2023)
Table 78. Global Biologics Monoclonal Antibodies Drug Consumption Value Forecast by Application (2024-2029)
Table 79. North America Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Biologics Monoclonal Antibodies Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Biologics Monoclonal Antibodies Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Biologics Monoclonal Antibodies Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Biologics Monoclonal Antibodies Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Biologics Monoclonal Antibodies Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Biologics Monoclonal Antibodies Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Biologics Monoclonal Antibodies Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Biologics Monoclonal Antibodies Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Biologics Monoclonal Antibodies Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Biologics Monoclonal Antibodies Drug Raw Material
Table 110. Key Suppliers of Biologics Monoclonal Antibodies Drug Raw Materials
Table 1. Global Biologics Monoclonal Antibodies Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biologics Monoclonal Antibodies Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biologics Monoclonal Antibodies Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biologics Monoclonal Antibodies Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Biologics Monoclonal Antibodies Drug Product and Solutions
Table 8. Roche Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Amgen Company Information, Head Office, and Major Competitors
Table 11. Amgen Major Business
Table 12. Amgen Biologics Monoclonal Antibodies Drug Product and Solutions
Table 13. Amgen Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Amgen Recent Developments and Future Plans
Table 15. AbbVie Company Information, Head Office, and Major Competitors
Table 16. AbbVie Major Business
Table 17. AbbVie Biologics Monoclonal Antibodies Drug Product and Solutions
Table 18. AbbVie Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. AbbVie Recent Developments and Future Plans
Table 20. Sanofi Company Information, Head Office, and Major Competitors
Table 21. Sanofi Major Business
Table 22. Sanofi Biologics Monoclonal Antibodies Drug Product and Solutions
Table 23. Sanofi Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Sanofi Recent Developments and Future Plans
Table 25. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 26. Johnson & Johnson Major Business
Table 27. Johnson & Johnson Biologics Monoclonal Antibodies Drug Product and Solutions
Table 28. Johnson & Johnson Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Johnson & Johnson Recent Developments and Future Plans
Table 30. Pfizer Company Information, Head Office, and Major Competitors
Table 31. Pfizer Major Business
Table 32. Pfizer Biologics Monoclonal Antibodies Drug Product and Solutions
Table 33. Pfizer Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Pfizer Recent Developments and Future Plans
Table 35. Eli Lilly Company Information, Head Office, and Major Competitors
Table 36. Eli Lilly Major Business
Table 37. Eli Lilly Biologics Monoclonal Antibodies Drug Product and Solutions
Table 38. Eli Lilly Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Eli Lilly Recent Developments and Future Plans
Table 40. Novartis Company Information, Head Office, and Major Competitors
Table 41. Novartis Major Business
Table 42. Novartis Biologics Monoclonal Antibodies Drug Product and Solutions
Table 43. Novartis Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Novartis Recent Developments and Future Plans
Table 45. Merck Company Information, Head Office, and Major Competitors
Table 46. Merck Major Business
Table 47. Merck Biologics Monoclonal Antibodies Drug Product and Solutions
Table 48. Merck Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Merck Recent Developments and Future Plans
Table 50. Biogen Company Information, Head Office, and Major Competitors
Table 51. Biogen Major Business
Table 52. Biogen Biologics Monoclonal Antibodies Drug Product and Solutions
Table 53. Biogen Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Biogen Recent Developments and Future Plans
Table 55. Sobi Company Information, Head Office, and Major Competitors
Table 56. Sobi Major Business
Table 57. Sobi Biologics Monoclonal Antibodies Drug Product and Solutions
Table 58. Sobi Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Sobi Recent Developments and Future Plans
Table 60. Innovent Biologics Company Information, Head Office, and Major Competitors
Table 61. Innovent Biologics Major Business
Table 62. Innovent Biologics Biologics Monoclonal Antibodies Drug Product and Solutions
Table 63. Innovent Biologics Biologics Monoclonal Antibodies Drug Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Innovent Biologics Recent Developments and Future Plans
Table 65. Global Biologics Monoclonal Antibodies Drug Revenue (USD Million) by Players (2018-2023)
Table 66. Global Biologics Monoclonal Antibodies Drug Revenue Share by Players (2018-2023)
Table 67. Breakdown of Biologics Monoclonal Antibodies Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 68. Market Position of Players in Biologics Monoclonal Antibodies Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 69. Head Office of Key Biologics Monoclonal Antibodies Drug Players
Table 70. Biologics Monoclonal Antibodies Drug Market: Company Product Type Footprint
Table 71. Biologics Monoclonal Antibodies Drug Market: Company Product Application Footprint
Table 72. Biologics Monoclonal Antibodies Drug New Market Entrants and Barriers to Market Entry
Table 73. Biologics Monoclonal Antibodies Drug Mergers, Acquisition, Agreements, and Collaborations
Table 74. Global Biologics Monoclonal Antibodies Drug Consumption Value (USD Million) by Type (2018-2023)
Table 75. Global Biologics Monoclonal Antibodies Drug Consumption Value Share by Type (2018-2023)
Table 76. Global Biologics Monoclonal Antibodies Drug Consumption Value Forecast by Type (2024-2029)
Table 77. Global Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2023)
Table 78. Global Biologics Monoclonal Antibodies Drug Consumption Value Forecast by Application (2024-2029)
Table 79. North America Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 80. North America Biologics Monoclonal Antibodies Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 81. North America Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 82. North America Biologics Monoclonal Antibodies Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 83. North America Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 84. North America Biologics Monoclonal Antibodies Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 85. Europe Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Europe Biologics Monoclonal Antibodies Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Europe Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 88. Europe Biologics Monoclonal Antibodies Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 89. Europe Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 90. Europe Biologics Monoclonal Antibodies Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 91. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 92. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 93. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 94. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 95. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 96. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 97. South America Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 98. South America Biologics Monoclonal Antibodies Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 99. South America Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 100. South America Biologics Monoclonal Antibodies Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 101. South America Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 102. South America Biologics Monoclonal Antibodies Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 104. Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 105. Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 106. Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 107. Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 108. Middle East & Africa Biologics Monoclonal Antibodies Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 109. Biologics Monoclonal Antibodies Drug Raw Material
Table 110. Key Suppliers of Biologics Monoclonal Antibodies Drug Raw Materials
LIST OF FIGURES
Figure 1. Biologics Monoclonal Antibodies Drug Picture
Figure 2. Global Biologics Monoclonal Antibodies Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type in 2022
Figure 4. Infliximab
Figure 5. Rituximab
Figure 6. Trastuzumab
Figure 7. Adalimumab
Figure 8. Other
Figure 9. Global Biologics Monoclonal Antibodies Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application in 2022
Figure 11. Cancer Picture
Figure 12. Autoimmune Disease Picture
Figure 13. Other Picture
Figure 14. Global Biologics Monoclonal Antibodies Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Biologics Monoclonal Antibodies Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Biologics Monoclonal Antibodies Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Region in 2022
Figure 19. North America Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Biologics Monoclonal Antibodies Drug Revenue Share by Players in 2022
Figure 25. Biologics Monoclonal Antibodies Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Biologics Monoclonal Antibodies Drug Market Share in 2022
Figure 27. Global Top 6 Players Biologics Monoclonal Antibodies Drug Market Share in 2022
Figure 28. Global Biologics Monoclonal Antibodies Drug Consumption Value Share by Type (2018-2023)
Figure 29. Global Biologics Monoclonal Antibodies Drug Market Share Forecast by Type (2024-2029)
Figure 30. Global Biologics Monoclonal Antibodies Drug Consumption Value Share by Application (2018-2023)
Figure 31. Global Biologics Monoclonal Antibodies Drug Market Share Forecast by Application (2024-2029)
Figure 32. North America Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. France Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Region (2018-2029)
Figure 49. China Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. India Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 66. Biologics Monoclonal Antibodies Drug Market Drivers
Figure 67. Biologics Monoclonal Antibodies Drug Market Restraints
Figure 68. Biologics Monoclonal Antibodies Drug Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Biologics Monoclonal Antibodies Drug in 2022
Figure 71. Manufacturing Process Analysis of Biologics Monoclonal Antibodies Drug
Figure 72. Biologics Monoclonal Antibodies Drug Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Biologics Monoclonal Antibodies Drug Picture
Figure 2. Global Biologics Monoclonal Antibodies Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type in 2022
Figure 4. Infliximab
Figure 5. Rituximab
Figure 6. Trastuzumab
Figure 7. Adalimumab
Figure 8. Other
Figure 9. Global Biologics Monoclonal Antibodies Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application in 2022
Figure 11. Cancer Picture
Figure 12. Autoimmune Disease Picture
Figure 13. Other Picture
Figure 14. Global Biologics Monoclonal Antibodies Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Biologics Monoclonal Antibodies Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Biologics Monoclonal Antibodies Drug Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Region in 2022
Figure 19. North America Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Biologics Monoclonal Antibodies Drug Revenue Share by Players in 2022
Figure 25. Biologics Monoclonal Antibodies Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Biologics Monoclonal Antibodies Drug Market Share in 2022
Figure 27. Global Top 6 Players Biologics Monoclonal Antibodies Drug Market Share in 2022
Figure 28. Global Biologics Monoclonal Antibodies Drug Consumption Value Share by Type (2018-2023)
Figure 29. Global Biologics Monoclonal Antibodies Drug Market Share Forecast by Type (2024-2029)
Figure 30. Global Biologics Monoclonal Antibodies Drug Consumption Value Share by Application (2018-2023)
Figure 31. Global Biologics Monoclonal Antibodies Drug Market Share Forecast by Application (2024-2029)
Figure 32. North America Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 42. France Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Region (2018-2029)
Figure 49. China Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 52. India Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Biologics Monoclonal Antibodies Drug Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Biologics Monoclonal Antibodies Drug Consumption Value (2018-2029) & (USD Million)
Figure 66. Biologics Monoclonal Antibodies Drug Market Drivers
Figure 67. Biologics Monoclonal Antibodies Drug Market Restraints
Figure 68. Biologics Monoclonal Antibodies Drug Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Biologics Monoclonal Antibodies Drug in 2022
Figure 71. Manufacturing Process Analysis of Biologics Monoclonal Antibodies Drug
Figure 72. Biologics Monoclonal Antibodies Drug Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source